查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1807613

手术缝合线市场（按材料、生物分解性、长丝、应用和最终用户）—2025-2030 年全球预测

Surgical Suture Market by Material, Biodegradability, Filament, Application, End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计手术缝线市场规模在 2024 年将达到 50.8 亿美元，2025 年将达到 53.8 亿美元，到 2030 年将达到 70.7 亿美元，复合年增长率为 5.66%。

主要市场统计数据
基准年2024年 50.8亿美元
预计2025年 53.8亿美元
预测年份 2030 70.7亿美元
复合年增长率（%） 5.66%

为全面研究影响全球医疗保健的手术缝合创新和市场动态奠定基础

外科缝合线市场透过伤口缝合技术影响癒合轨迹和病患安全，在改善全球医疗保健结果方面发挥关键作用。缝合线是外科手术的基本组成部分，在提供机械支撑的同时，最大限度地降低感染风险，并促进最佳组织再生。随着手术日益复杂和患者群体老化，对创新缝合解决方案的需求日益增长。

揭示关键的技术、监管和临床进展，重新定义整个医疗生态系统的手术缝合市场格局

由于技术创新的快速发展、法律规范的不断演变以及临床应用的不断变化，外科缝合线产业正在经历重大变革时期。生物活性涂层、药物释放型线丝以及新一代可吸收聚合物等创新技术正在重新定义伤口缝合的有效性。因此，製造商正在大力投入研发，力求将抗菌特性和控制释放疗法直接融入缝线基质，从而减少术后併发症并加速患者復健。

评估2025年美国新关税对供应链、定价结构和产业竞争的深远影响

2025年美国新关税的实施将给依赖进口原料和成品缝合线的公司带来巨大的成本挑战。尤其是特殊聚合物和钴基针头合金关税的提高，将对整个供应链产生连锁反应，促使製造商重新评估筹资策略。因此，许多组织正在探索与本地製造商的合作，以降低进口成本并保持具有竞争力的价格。

揭示材料成分、生物分解性特性、长丝结构、临床应用和最终用户环境的关键见解，以指导市场策略

透过材料成分分析市场，可以发现天然纤维和合成纤维的性能差异。天然纤维具有更高的生物相容性，尤其适用于精细手术；而合成聚合物则具有稳定的拉伸强度和可预测的吸收率。因此，这两类材料之间的选择取决于手术要求和外科医生的偏好。

分析美洲、欧洲、中东和非洲以及亚太地区的区域表现和成长动力，揭示独特的市场动态和战略驱动力

不同的医疗基础设施、法规环境和创新生态系统决定了不同地区对手术缝合线需求的差异。在美洲，强大的报销框架、良好的医院网路以及强劲的国内製造能力，为先进缝合技术的持续应用提供了支援。此外，积极的公私合作研究计画正在强化产品平臺，并加速临床检验。

介绍领先的手术缝合线製造商，其有效的策略和策略联盟推动了动态医疗保健市场的创新、扩充性和竞争差异化

外科缝合领域的主要参与企业已利用研发方面的策略投资来建立竞争优势。老牌医疗设备集团透过有针对性地收购专注于可吸收聚合物和抗菌涂层的利基生物技术创新公司，扩大了其产品组合，从而保持了广泛的产品系列，以满足不同的临床需求和价格分布。

提供策略建议，以推动创新管道、加强供应链并增强临床伙伴关係模式，实现永续成长

产业领导者应优先考虑整合兼具机械强度、抗菌和药物传递功能的多功能生医材料。投资模组化研发框架可以加速产品的迭代改进，并支援在不断变化的监管标准下进行快速测试。此外，与临床研究机构建立伙伴关係，可以促进下一代丝材在实际手术环境中的早期检验。

结合次要分析、专家访谈和资料三角测量的全面、多阶段调查方法确保了分析的严谨性

本分析基于严格的多阶段调查方法，旨在确保数据可靠性和对外科缝合线市场的全面覆盖。首先，对同行评审日誌、监管文件和行业出版物进行了广泛的二次审查，建立了对技术趋势、材料科学进展和政策发展的基础了解。

总结关键发现和策略意义，为相关人员提供外科缝线投资、开发和竞争差异化的明确方向

总而言之，外科缝线市场正处于一个关键的曲折点，技术创新、监管变革和供应链重组正在交汇，重新定义竞争格局。材料进步和多功能线材设计正在开启新的临床应用可能性，而关税的实施凸显了多元化采购和区域製造策略的必要性。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章市场动态

  • 腹腔镜和机器人手术中越来越多地采用倒钩缝合线，提高了手术效率和患者预后
  • 关注抗菌缝合涂层，降低高风险手术患者术后感染率
  • 开发生物可吸收水凝胶缝合材料以促进组织再生并减少疤痕形成
  • 将智慧缝合技术与生物感测器结合，实现即时伤口监测和感染检测
  • 人们对无结缝合器械的需求日益增长，因为这种器械可以方便地进行微创和内视镜手术，并能安全地进入组织。
  • 结合止血和抗菌特性的多功能缝合涂层在复杂伤口处理的应用进展
  • 利用组织黏附微球进行缝合扩张，以促进止血并促进创伤护理中伤口缝合
  • 用于加速药物传输和将治疗剂定向释放到伤口部位的奈米工程缝合纤维的研究正在蓬勃发展
  • 转向环保缝合线包装和生物分解性材料，以减少医疗废弃物和碳排放
  • 加强缝合线製造商与生技公司的合作，开发适合患者基因组的个人化再生缝合线解决方案

第六章 市场洞察

  • 波特五力分析
  • PESTEL分析

第七章 2025年美国关税的累积影响

第 8 章：外科缝线市场（按材料）

  • 自然的
  • 合成

9. 外科缝合线市场（依生物分解）

  • 吸收性
  • 不可吸收

第十章手术缝合线市场

  • 单丝
  • 多丝纤维

第 11 章。按应用分類的手术缝合线市场

  • 心血管手术
    • 冠状动脉绕道手术手术（CABG）
    • 心臟瓣膜修復/置换
  • 一般外科
  • 神经外科
  • 眼科手术
    • 白内障手术
    • 角膜移植
  • 整形外科
    • 关节镜
    • 骨折固定和韧带修復
    • 关节重建
  • 整形外科/重组外科
    • 乳房重建
    • 整容手术

第 12 章 手术缝线市场（依最终使用者）

  • 门诊手术中心（ASC）
  • 诊所
  • 医院
  • 研究和学术机构

13.美洲外科缝合线市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

14.欧洲、中东和非洲手术缝线市场

  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 阿拉伯聯合大公国
  • 沙乌地阿拉伯
  • 南非
  • 丹麦
  • 荷兰
  • 卡达
  • 芬兰
  • 瑞典
  • 奈及利亚
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波兰
  • 瑞士

15.亚太外科缝合线市场

  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 印尼
  • 泰国
  • 菲律宾
  • 马来西亚
  • 新加坡
  • 越南
  • 台湾

第十六章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Advanced Medical Solutions Group plc
    • B. Braun SE
    • CONMED Corporation
    • DemeTECH Corporation
    • Healthium Medtech Ltd.
    • Johnson & Johnson Services, Inc.
    • Lotus Surgicals Pvt Ltd
    • Medtronic PLC
    • Mellon Medical BV
    • Smith & Nephew PLC
    • Stryker Corporation
    • Corza Medical GmbH
    • Unisur Lifecare Pvt. Ltd.
    • Zimmer Biomet Holdings, Inc.
    • Teleflex Incorporated
    • GMD Group
    • Atramat by Internacional Farmaceutica SA . de CV
    • Shandong Haidike Medical Products Co.,Ltd.
    • Demophorius Healthcare Ltd.
    • AIP Medical SA
    • Vitrex Medical A/S
    • Lux Sutures SA
    • Sutumed Corp.
    • Centenial Surgical Suture Ltd.
    • Orion Sutures India Pvt Ltd
    • Dolphin Sutures
    • AD Surgical
    • McKesson Medical-Surgical Inc.
    • SUTUREGARD Medical, Inc.
    • Genesis Medtech
    • Lydus Medical
    • Riverpoint Medical
    • Able Medical Devices Inc.

第十七章 研究人工智慧

第十八章 研究统计

第十九章 研究联络人

第二十章 研究报导

第21章 附录

Product Code: MRR-FD3F12D52777

The Surgical Suture Market was valued at USD 5.08 billion in 2024 and is projected to grow to USD 5.38 billion in 2025, with a CAGR of 5.66%, reaching USD 7.07 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 5.08 billion
Estimated Year [2025] USD 5.38 billion
Forecast Year [2030] USD 7.07 billion
CAGR (%) 5.66%

Setting the Stage for a Comprehensive Exploration of Surgical Suture Innovations and Market Dynamics Impacting Global Healthcare

The surgical suture market plays a pivotal role in advancing global healthcare outcomes through wound closure techniques that influence healing trajectories and patient safety. Sutures form a foundational component of surgical practice, providing mechanical support while minimizing infection risk and promoting optimal tissue regeneration. As procedures grow increasingly complex and patient populations age, the demand for innovative suture solutions continues to intensify.

This executive summary delivers a comprehensive overview of the key trends, regulatory shifts, and competitive dynamics shaping the surgical suture landscape. It synthesizes insights across material innovations, biodegradability considerations, filament technologies, application domains, and end-user channels to guide decision-makers in aligning their strategies with emerging market realities. Furthermore, it examines the implications of recent policy changes, including the introduction of new tariffs, which are poised to influence cost structures and supply chain resilience.

Drawing upon expert interviews, secondary research, and rigorous data validation, this summary offers a concise yet thorough narrative designed to inform stakeholders in device manufacturing, clinical practice, investment, and policy development. By navigating through transformative shifts, segmentation analyses, regional nuances, and competitive positioning, readers will gain an integrated perspective to drive informed action and sustained growth in the surgical suture sector.

Unveiling the Pivotal Technological, Regulatory, and Clinical Advancements Redefining the Surgical Suture Market Landscape Across the Healthcare Ecosystem

The surgical suture industry is undergoing a period of profound transformation driven by rapid technological breakthroughs, evolving regulatory frameworks, and shifting clinical practices. Innovations such as bioactive coatings, drug-eluting filaments, and next-generation absorbable polymers are redefining the parameters of wound closure efficacy. Consequently, manufacturers are investing heavily in research to integrate antimicrobial properties and controlled-release therapeutics directly into suture matrices, thereby reducing postoperative complications and expediting patient recovery.

Simultaneously, regulatory bodies are tightening quality and safety standards, mandating enhanced traceability and rigorous performance testing. This trend has accelerated the adoption of digital tracking systems and advanced sterilization protocols, ensuring that sutures meet the stringent demands of global healthcare providers. Moreover, the rise of minimally invasive and robotic-assisted surgical techniques has heightened the need for precision-engineered filaments capable of navigating delicate anatomical structures.

In parallel, sustainability considerations have prompted a shift toward eco-friendly materials that address the environmental impact of synthetic polymers. Biodegradable options are gaining traction among clinicians seeking to balance performance with ecological responsibility. As a result, the confluence of clinical, regulatory, and environmental drivers is setting new benchmarks for product development, compelling industry participants to adapt swiftly or risk obsolescence.

Assessing the Far-Reaching Effects of Newly Implemented United States Tariffs in 2025 on Supply Chains, Pricing Structures, and Industry Competitiveness

The implementation of new United States tariffs in 2025 has introduced significant cost challenges for companies reliant on imported raw materials and finished suture products. In particular, higher duties on specialized polymers and cobalt-based needle alloys have reverberated through supply chains, prompting manufacturers to reassess their sourcing strategies. As a result, many organizations are exploring localized production partnerships to mitigate import expenses and maintain competitive pricing structures.

Moreover, distributors and healthcare providers have felt the impact through elevated procurement costs, which have necessitated renegotiations of supply contracts and spurred interest in alternative filament technologies that are exempt from the newest tariff classifications. Consequently, synthetic polymer suppliers within the U.S. have seen heightened demand, leveraging their domestic footprint to offer expedited fulfillment and reduced duty burdens.

However, this recalibration has not been without its trade-offs. Transitioning to alternative suppliers often entails extended lead times and additional validation processes, introducing potential risks to inventory continuity. To that end, industry participants are investing in dual-sourcing models and strategic stockpiling to safeguard against supply disruptions. In sum, the 2025 tariff adjustments have accentuated the importance of supply chain agility and cost management as critical success factors in the surgical suture market.

Illuminating Critical Insights Across Material Composition, Biodegradability Profiles, Filament Architectures, Clinical Applications, and End-User Environments to Guide Market Strategies

Analyzing the market through the lens of material composition reveals divergent performance profiles between natural and synthetic sutures. Natural fibers offer biocompatibility advantages, particularly in delicate procedures, whereas synthetic polymers deliver consistent tensile strength and predictable absorption rates. Consequently, the choice between these two categories hinges on procedural requirements and surgeon preferences.

Turning to biodegradability, absorbable sutures have gained prominence in scenarios where secondary removal procedures pose additional risk, while non-absorbable filaments persist in applications demanding prolonged mechanical support, such as cardiovascular anastomoses. This distinction shapes product development priorities and inventory management protocols across healthcare institutions.

Examining filament structure, monofilament designs minimize tissue drag and reduce infection risk, making them preferable for skin closures and urologic repairs. In contrast, multifilament constructs enhance knot security and pliability, which supports their adoption in gastrointestinal and orthopedic surgeries. The interplay between filament type and clinical context informs surgeon selection and procurement strategies.

When considering the application spectrum, sutures tailored for cardiac surgery must accommodate coronary artery bypass grafting and heart valve repair with precision, while ophthalmic options address cataract surgery and corneal transplantation through ultra-fine gauge materials. Orthopedic use cases range from arthroscopy to fracture fixation and joint replacement, demanding robust tensile performance. Plastic and reconstructive procedures, encompassing breast reconstruction and cosmetic enhancements, prioritize both structural integrity and aesthetic outcomes.

Finally, end-user dynamics span ambulatory surgical centers seeking cost-effective, streamlined solutions; clinics requiring ready-to-use kits; hospitals demanding broad product portfolios; and research and academic institutes focused on experimental biomaterials. This multifaceted segmentation underscores the necessity for customized offerings that align with the distinct priorities of each customer group.

Dissecting Regional Performance and Growth Drivers Within the Americas, Europe Middle East & Africa, and Asia Pacific to Reveal Unique Market Dynamics and Strategic Imperatives

Regional variations in surgical suture demand are shaped by distinct healthcare infrastructures, regulatory environments, and innovation ecosystems. Within the Americas, strong reimbursement frameworks, established hospital networks, and robust domestic manufacturing capabilities drive sustained adoption of advanced suture technologies. Furthermore, proactive public-private collaborations in research initiatives bolster product pipelines and accelerate clinical validation.

In contrast, Europe, Middle East & Africa presents a mosaic of regulatory standards and procurement practices. While Western European markets prioritize high-performance, bioactive sutures supported by extensive clinical data, emerging markets in the Middle East and Africa are increasingly investing in capacity-building to meet rising surgical volumes. Collaborative efforts to harmonize standards and streamline approval processes are elevating regional competitiveness.

Meanwhile, the Asia-Pacific region has emerged as a powerhouse for both production and consumption. Rapid healthcare modernization, growing surgical volumes, and expanding medical tourism have fueled demand for cost-effective yet innovative suture solutions. Local manufacturers are scaling up capabilities to supply both domestic and export markets, while multinational corporations forge partnerships to navigate diverse regulatory frameworks and leverage distribution networks.

Together, these regional insights highlight the importance of tailoring market entry and growth strategies to align with localized regulatory landscapes, clinical practices, and supply chain considerations. By recognizing the nuanced drivers within each geography, companies can optimize product positioning and resource allocation to capture emerging opportunities.

Profiling Leading Surgical Suture Manufacturers and Their Strategic Collaborations Fueling Innovation, Scalability, and Competitive Differentiation in a Dynamic Healthcare Market

Leading participants in the surgical suture domain have leveraged strategic investments in research and development to establish competitive moats. Established medical device conglomerates have expanded their portfolios through targeted acquisitions of niche biotech innovators specializing in absorbable polymers and antimicrobial coatings. As a result, they maintain a broad product range that addresses diverse clinical requirements and price points.

At the same time, specialized manufacturers have distinguished themselves by focusing on next-generation biomaterials, such as bioresorbable copolymers and drug-infused filaments, enabling them to capture share in high-growth segments. Through collaborations with academic research centers, these companies benefit from early access to experimental data and can accelerate product commercialization timelines.

Distribution partners have also played a pivotal role by integrating digital procurement platforms, which provide real-time visibility into stock levels, usage trends, and performance outcomes. These systems enhance decision support for healthcare providers and reinforce supplier relationships.

Additionally, alliances between device producers and contract manufacturing organizations have streamlined scale-up processes, reducing time to market for innovative offerings. By combining technological expertise with manufacturing agility, these partnerships enable rapid response to shifting clinical demands and emerging tariff constraints.

Overall, the market's competitive landscape is defined by the interplay between legacy manufacturers, agile niche players, and value-added distributors, each contributing to a dynamic environment of continuous innovation and strategic repositioning.

Delivering Strategic Recommendations to Drive Innovation Pipelines, Strengthen Supply Chain Resilience, and Enhance Clinical Partnership Models for Sustainable Growth

Industry leaders should prioritize the integration of multifunctional biomaterials that combine mechanical strength with antimicrobial and drug-delivery capabilities. Investing in modular R&D frameworks will accelerate iterative product enhancements and support rapid testing under evolving regulatory standards. Moreover, cultivating partnerships with clinical research institutions can facilitate early validation of next-generation filaments in real-world surgical settings.

In light of supply chain uncertainties accentuated by new tariffs, organizations must develop dual-sourcing strategies and evaluate regional manufacturing alliances to secure material access and mitigate cost volatility. Establishing strategic stock reserves and leveraging contract manufacturing relationships will enhance agility and maintain continuity of supply.

Furthermore, enhancing digital engagement with healthcare providers through integrated procurement and performance-tracking platforms will yield actionable usage data. This intelligence can inform targeted marketing efforts, optimize product mix, and strengthen customer loyalty by demonstrating clinical value in quantifiable terms.

To capture emerging opportunities in high-growth applications, firms should tailor their portfolio to address specialized procedures such as robotic-assisted minimally invasive surgeries and reconstructive interventions. Customizing suture solutions for these niches will position companies as preferred partners for advanced surgical care.

Finally, embedding sustainability targets into product development roadmaps-by reducing environmental impact of polymers and packaging-will align with global healthcare sustainability mandates and resonate with environmentally conscious stakeholders.

Detailing a Comprehensive Multistage Research Methodology Blending Secondary Analysis, Expert Interviews, and Data Triangulation to Ensure Analytical Rigor

This analysis is grounded in a rigorous, multistage research methodology designed to ensure data reliability and comprehensive coverage of the surgical suture market. Initially, an extensive secondary review of peer-reviewed journals, regulatory filings, and industry publications established baseline understanding of technological trends, material science advances, and policy developments.

Subsequently, primary interviews were conducted with a cross-section of stakeholders, including senior executives from leading medical device manufacturers, procurement leaders at major healthcare systems, and key opinion leaders specializing in surgical practice. These in-depth conversations provided nuanced perspectives on clinical requirements, unmet needs, and adoption barriers.

Quantitative data was triangulated through data validation protocols, comparing trade statistics, patent filings, and public financial disclosures to ensure consistency and accuracy. Advanced analytical models were then applied to identify correlations between segmentation variables and market dynamics.

Throughout the research process, iterative quality checks and peer reviews were implemented to uphold methodological rigor. This robust approach combines qualitative insights with empirical evidence, furnishing a solid foundation for the strategic findings and recommendations presented in this summary.

Summarizing Core Findings and Strategic Implications to Empower Stakeholders With Clear Directions for Investment, Development, and Competitive Differentiation in Surgical Sutures

In conclusion, the surgical suture market stands at a critical inflection point where technological innovation, regulatory evolution, and supply chain realignment converge to redefine competitive landscapes. Material advancements and multifunctional filament designs are unlocking new clinical possibilities, while the introduction of tariffs has underscored the necessity of diversified sourcing and regional manufacturing strategies.

Segmentation insights reveal that customizing suture solutions across material types, biodegradability profiles, filament structures, application areas, and end-user channels is paramount to meeting diverse clinical demands. Regional intelligence highlights that strategic market entries must consider localized regulatory requirements and distribution paradigms to maximize impact.

Key players are forging strategic alliances, investing in digital procurement platforms, and expanding their portfolios through targeted acquisitions to maintain market leadership. Industry stakeholders must respond by aligning innovation roadmaps with emerging procedural trends, reinforcing supply chain flexibility, and embedding sustainability into their core strategies.

By synthesizing these insights and recommendations, decision-makers are equipped with a clear blueprint to navigate the unfolding opportunities and challenges of the surgical suture arena, driving sustained value creation and improved patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Rising adoption of barbed sutures for laparoscopic and robotic surgical procedures improving operative efficiency and patient outcomes
  • 5.2. Increased focus on antimicrobial suture coatings to reduce postoperative infection rates in high-risk surgical patients
  • 5.3. Development of bioabsorbable hydrogel-based suture materials for enhanced tissue regeneration and reduced scar formation
  • 5.4. Integration of smart suture technologies with biosensors for real-time wound monitoring and infection detection
  • 5.5. Growing demand for knotless suture devices facilitating minimally invasive and endoscopic surgeries with secure tissue approximation
  • 5.6. Advancements in multifunctional suture coatings combining hemostatic and antimicrobial properties for complex wound management
  • 5.7. Expansion of sutures with tissue adhesive microspheres to accelerate hemostasis and promote faster wound closure in trauma care
  • 5.8. Surge in research on nano-engineered suture fibers for accelerated drug delivery and targeted therapeutic release at wound sites
  • 5.9. Shift towards environmentally sustainable suture packaging and biodegradable materials to reduce medical waste and carbon footprint
  • 5.10. Increased collaboration between suture manufacturers and biotech firms to develop personalized regenerative suture solutions tailored to patient genomics

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Surgical Suture Market, by Material

  • 8.1. Introduction
  • 8.2. Natural
  • 8.3. Synthetic

9. Surgical Suture Market, by Biodegradability

  • 9.1. Introduction
  • 9.2. Absorbable
  • 9.3. Non Absorbable

10. Surgical Suture Market, by Filament

  • 10.1. Introduction
  • 10.2. Monofilament
  • 10.3. Multifilament

11. Surgical Suture Market, by Application

  • 11.1. Introduction
  • 11.2. Cardiac Surgery
    • 11.2.1. Coronary Artery Bypass Grafting (CABG)
    • 11.2.2. Heart Valve Repair/Replacement
  • 11.3. General Surgery
  • 11.4. Neurological Surgery
  • 11.5. Ophthalmic Surgery
    • 11.5.1. Cataract Surgery
    • 11.5.2. Corneal Transplantation
  • 11.6. Orthopedic Surgery
    • 11.6.1. Arthroscopy
    • 11.6.2. Fracture Fixation & Ligament Repair
    • 11.6.3. Joint Replacement
  • 11.7. Plastic & Reconstructive Surgery
    • 11.7.1. Breast Reconstruction
    • 11.7.2. Cosmetic Procedures

12. Surgical Suture Market, by End-user

  • 12.1. Introduction
  • 12.2. Ambulatory Surgical Centers (ASCs)
  • 12.3. Clinics
  • 12.4. Hospitals
  • 12.5. Research & Academic Institutes

13. Americas Surgical Suture Market

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. Argentina

14. Europe, Middle East & Africa Surgical Suture Market

  • 14.1. Introduction
  • 14.2. United Kingdom
  • 14.3. Germany
  • 14.4. France
  • 14.5. Russia
  • 14.6. Italy
  • 14.7. Spain
  • 14.8. United Arab Emirates
  • 14.9. Saudi Arabia
  • 14.10. South Africa
  • 14.11. Denmark
  • 14.12. Netherlands
  • 14.13. Qatar
  • 14.14. Finland
  • 14.15. Sweden
  • 14.16. Nigeria
  • 14.17. Egypt
  • 14.18. Turkey
  • 14.19. Israel
  • 14.20. Norway
  • 14.21. Poland
  • 14.22. Switzerland

15. Asia-Pacific Surgical Suture Market

  • 15.1. Introduction
  • 15.2. China
  • 15.3. India
  • 15.4. Japan
  • 15.5. Australia
  • 15.6. South Korea
  • 15.7. Indonesia
  • 15.8. Thailand
  • 15.9. Philippines
  • 15.10. Malaysia
  • 15.11. Singapore
  • 15.12. Vietnam
  • 15.13. Taiwan

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Advanced Medical Solutions Group plc
    • 16.3.2. B. Braun SE
    • 16.3.3. CONMED Corporation
    • 16.3.4. DemeTECH Corporation
    • 16.3.5. Healthium Medtech Ltd.
    • 16.3.6. Johnson & Johnson Services, Inc.
    • 16.3.7. Lotus Surgicals Pvt Ltd
    • 16.3.8. Medtronic PLC
    • 16.3.9. Mellon Medical B.V.
    • 16.3.10. Smith & Nephew PLC
    • 16.3.11. Stryker Corporation
    • 16.3.12. Corza Medical GmbH
    • 16.3.13. Unisur Lifecare Pvt. Ltd.
    • 16.3.14. Zimmer Biomet Holdings, Inc.
    • 16.3.15. Teleflex Incorporated
    • 16.3.16. GMD Group
    • 16.3.17. Atramat by Internacional Farmaceutica S.A . de C.V.
    • 16.3.18. Shandong Haidike Medical Products Co.,Ltd.
    • 16.3.19. Demophorius Healthcare Ltd.
    • 16.3.20. AIP Medical SA
    • 16.3.21. Vitrex Medical A/S
    • 16.3.22. Lux Sutures SA
    • 16.3.23. Sutumed Corp.
    • 16.3.24. Centenial Surgical Suture Ltd.
    • 16.3.25. Orion Sutures India Pvt Ltd
    • 16.3.26. Dolphin Sutures
    • 16.3.27. AD Surgical
    • 16.3.28. McKesson Medical-Surgical Inc.
    • 16.3.29. SUTUREGARD Medical, Inc.
    • 16.3.30. Genesis Medtech
    • 16.3.31. Lydus Medical
    • 16.3.32. Riverpoint Medical
    • 16.3.33. Able Medical Devices Inc.

17. ResearchAI

18. ResearchStatistics

19. ResearchContacts

20. ResearchArticles

21. Appendix

LIST OF FIGURES

  • FIGURE 1. SURGICAL SUTURE MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL SURGICAL SUTURE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL SURGICAL SUTURE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL SURGICAL SUTURE MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL SURGICAL SUTURE MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 16. AMERICAS SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 18. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. SURGICAL SUTURE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 24. SURGICAL SUTURE MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 25. SURGICAL SUTURE MARKET: RESEARCHAI
  • FIGURE 26. SURGICAL SUTURE MARKET: RESEARCHSTATISTICS
  • FIGURE 27. SURGICAL SUTURE MARKET: RESEARCHCONTACTS
  • FIGURE 28. SURGICAL SUTURE MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. SURGICAL SUTURE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SURGICAL SUTURE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL SUTURE MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL SUTURE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL SUTURE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL SUTURE MARKET SIZE, BY NATURAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL SUTURE MARKET SIZE, BY NATURAL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL SUTURE MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL SUTURE MARKET SIZE, BY SYNTHETIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL SUTURE MARKET SIZE, BY ABSORBABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL SUTURE MARKET SIZE, BY ABSORBABLE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL SUTURE MARKET SIZE, BY NON ABSORBABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL SUTURE MARKET SIZE, BY NON ABSORBABLE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL SUTURE MARKET SIZE, BY MONOFILAMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL SUTURE MARKET SIZE, BY MONOFILAMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL SUTURE MARKET SIZE, BY MULTIFILAMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL SUTURE MARKET SIZE, BY MULTIFILAMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING (CABG), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING (CABG), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL SUTURE MARKET SIZE, BY HEART VALVE REPAIR/REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL SUTURE MARKET SIZE, BY HEART VALVE REPAIR/REPLACEMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL SUTURE MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL SUTURE MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL SUTURE MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL SUTURE MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CATARACT SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CATARACT SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CORNEAL TRANSPLANTATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CORNEAL TRANSPLANTATION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL SURGICAL SUTURE MARKET SIZE, BY ARTHROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL SUTURE MARKET SIZE, BY ARTHROSCOPY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL SURGICAL SUTURE MARKET SIZE, BY FRACTURE FIXATION & LIGAMENT REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL SURGICAL SUTURE MARKET SIZE, BY FRACTURE FIXATION & LIGAMENT REPAIR, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL SURGICAL SUTURE MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL SURGICAL SUTURE MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL SURGICAL SUTURE MARKET SIZE, BY BREAST RECONSTRUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL SURGICAL SUTURE MARKET SIZE, BY BREAST RECONSTRUCTION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL SURGICAL SUTURE MARKET SIZE, BY COSMETIC PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL SURGICAL SUTURE MARKET SIZE, BY COSMETIC PROCEDURES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL SURGICAL SUTURE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL SURGICAL SUTURE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL SURGICAL SUTURE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL SURGICAL SUTURE MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL SURGICAL SUTURE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL SURGICAL SUTURE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL SURGICAL SUTURE MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL SURGICAL SUTURE MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. AMERICAS SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 78. AMERICAS SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 79. AMERICAS SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2024 (USD MILLION)
  • TABLE 80. AMERICAS SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2025-2030 (USD MILLION)
  • TABLE 81. AMERICAS SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2024 (USD MILLION)
  • TABLE 82. AMERICAS SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2025-2030 (USD MILLION)
  • TABLE 83. AMERICAS SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 84. AMERICAS SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 85. AMERICAS SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 86. AMERICAS SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 87. AMERICAS SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 88. AMERICAS SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 89. AMERICAS SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 90. AMERICAS SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 91. AMERICAS SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 92. AMERICAS SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2025-2030 (USD MILLION)
  • TABLE 93. AMERICAS SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 94. AMERICAS SURGICAL SUTURE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 95. AMERICAS SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. AMERICAS SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 97. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 98. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 99. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2024 (USD MILLION)
  • TABLE 100. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2025-2030 (USD MILLION)
  • TABLE 101. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2024 (USD MILLION)
  • TABLE 102. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2025-2030 (USD MILLION)
  • TABLE 103. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 104. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 105. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 106. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 107. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 108. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 109. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 110. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 111. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 112. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2025-2030 (USD MILLION)
  • TABLE 113. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 114. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 115. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 116. UNITED STATES SURGICAL SUTURE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 117. CANADA SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 118. CANADA SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 119. CANADA SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2024 (USD MILLION)
  • TABLE 120. CANADA SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2025-2030 (USD MILLION)
  • TABLE 121. CANADA SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2024 (USD MILLION)
  • TABLE 122. CANADA SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2025-2030 (USD MILLION)
  • TABLE 123. CANADA SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 124. CANADA SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 125. CANADA SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 126. CANADA SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 127. CANADA SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 128. CANADA SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 129. CANADA SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 130. CANADA SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 131. CANADA SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 132. CANADA SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2025-2030 (USD MILLION)
  • TABLE 133. CANADA SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 134. CANADA SURGICAL SUTURE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 135. MEXICO SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 136. MEXICO SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 137. MEXICO SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2024 (USD MILLION)
  • TABLE 138. MEXICO SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2025-2030 (USD MILLION)
  • TABLE 139. MEXICO SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2024 (USD MILLION)
  • TABLE 140. MEXICO SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2025-2030 (USD MILLION)
  • TABLE 141. MEXICO SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 142. MEXICO SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 143. MEXICO SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 144. MEXICO SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 145. MEXICO SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 146. MEXICO SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 147. MEXICO SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 148. MEXICO SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 149. MEXICO SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 150. MEXICO SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2025-2030 (USD MILLION)
  • TABLE 151. MEXICO SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 152. MEXICO SURGICAL SUTURE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 153. BRAZIL SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 154. BRAZIL SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 155. BRAZIL SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2024 (USD MILLION)
  • TABLE 156. BRAZIL SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2025-2030 (USD MILLION)
  • TABLE 157. BRAZIL SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2024 (USD MILLION)
  • TABLE 158. BRAZIL SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2025-2030 (USD MILLION)
  • TABLE 159. BRAZIL SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 160. BRAZIL SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 161. BRAZIL SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 162. BRAZIL SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 163. BRAZIL SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 164. BRAZIL SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 165. BRAZIL SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 166. BRAZIL SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 167. BRAZIL SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 168. BRAZIL SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2025-2030 (USD MILLION)
  • TABLE 169. BRAZIL SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 170. BRAZIL SURGICAL SUTURE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 171. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 172. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 173. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2024 (USD MILLION)
  • TABLE 174. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2025-2030 (USD MILLION)
  • TABLE 175. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2024 (USD MILLION)
  • TABLE 176. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2025-2030 (USD MILLION)
  • TABLE 177. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 178. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 179. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 180. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 181. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 182. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 183. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 184. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 185. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 186. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2025-2030 (USD MILLION)
  • TABLE 187. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 188. ARGENTINA SURGICAL SUTURE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2025-2030 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2025-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2025-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA SURGICAL SUTURE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 209. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 210. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 211. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2024 (USD MILLION)
  • TABLE 212. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2025-2030 (USD MILLION)
  • TABLE 213. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2024 (USD MILLION)
  • TABLE 214. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2025-2030 (USD MILLION)
  • TABLE 215. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 216. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 217. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 218. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 219. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 220. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 221. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 222. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 223. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 224. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2025-2030 (USD MILLION)
  • TABLE 225. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 226. UNITED KINGDOM SURGICAL SUTURE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 227. GERMANY SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 228. GERMANY SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 229. GERMANY SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2024 (USD MILLION)
  • TABLE 230. GERMANY SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2025-2030 (USD MILLION)
  • TABLE 231. GERMANY SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2024 (USD MILLION)
  • TABLE 232. GERMANY SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2025-2030 (USD MILLION)
  • TABLE 233. GERMANY SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 234. GERMANY SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 235. GERMANY SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 236. GERMANY SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 237. GERMANY SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 238. GERMANY SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 239. GERMANY SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 240. GERMANY SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 241. GERMANY SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 242. GERMANY SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2025-2030 (USD MILLION)
  • TABLE 243. GERMANY SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 244. GERMANY SURGICAL SUTURE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 245. FRANCE SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 246. FRANCE SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 247. FRANCE SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2024 (USD MILLION)
  • TABLE 248. FRANCE SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2025-2030 (USD MILLION)
  • TABLE 249. FRANCE SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2024 (USD MILLION)
  • TABLE 250. FRANCE SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2025-2030 (USD MILLION)
  • TABLE 251. FRANCE SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. FRANCE SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 253. FRANCE SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 254. FRANCE SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 255. FRANCE SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 256. FRANCE SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 257. FRANCE SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 258. FRANCE SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 259. FRANCE SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 260. FRANCE SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2025-2030 (USD MILLION)
  • TABLE 261. FRANCE SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 262. FRANCE SURGICAL SUTURE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 263. RUSSIA SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 264. RUSSIA SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 265. RUSSIA SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2024 (USD MILLION)
  • TABLE 266. RUSSIA SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2025-2030 (USD MILLION)
  • TABLE 267. RUSSIA SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2024 (USD MILLION)
  • TABLE 268. RUSSIA SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2025-2030 (USD MILLION)
  • TABLE 269. RUSSIA SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 270. RUSSIA SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 271. RUSSIA SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 272. RUSSIA SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 273. RUSSIA SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 274. RUSSIA SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 275. RUSSIA SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 276. RUSSIA SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 277. RUSSIA SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 278. RUSSIA SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2025-2030 (USD MILLION)
  • TABLE 279. RUSSIA SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 280. RUSSIA SURGICAL SUTURE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 281. ITALY SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 282. ITALY SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 283. ITALY SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2024 (USD MILLION)
  • TABLE 284. ITALY SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2025-2030 (USD MILLION)
  • TABLE 285. ITALY SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2024 (USD MILLION)
  • TABLE 286. ITALY SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2025-2030 (USD MILLION)
  • TABLE 287. ITALY SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. ITALY SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 289. ITALY SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 290. ITALY SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 291. ITALY SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 292. ITALY SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 293. ITALY SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 294. ITALY SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 295. ITALY SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 296. ITALY SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2025-2030 (USD MILLION)
  • TABLE 297. ITALY SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 298. ITALY SURGICAL SUTURE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 299. SPAIN SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 300. SPAIN SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 301. SPAIN SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2024 (USD MILLION)
  • TABLE 302. SPAIN SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2025-2030 (USD MILLION)
  • TABLE 303. SPAIN SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2024 (USD MILLION)
  • TABLE 304. SPAIN SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2025-2030 (USD MILLION)
  • TABLE 305. SPAIN SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 306. SPAIN SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 307. SPAIN SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 308. SPAIN SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 309. SPAIN SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 310. SPAIN SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 311. SPAIN SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 312. SPAIN SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 313. SPAIN SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 314. SPAIN SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2025-2030 (USD MILLION)
  • TABLE 315. SPAIN SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 316. SPAIN SURGICAL SUTURE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 318. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 319. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2024 (USD MILLION)
  • TABLE 320. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2025-2030 (USD MILLION)
  • TABLE 321. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2024 (USD MILLION)
  • TABLE 322. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2025-2030 (USD MILLION)
  • TABLE 323. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 324. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 325. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 326. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 327. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 328. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY OPHTHALMIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 329. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 330. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2030 (USD MILLION)
  • TABLE 331. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 332. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2025-2030 (USD MILLION)
  • TABLE 333. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 334. UNITED ARAB EMIRATES SURGICAL SUTURE MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 335. SAUDI ARABIA SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 336. SAUDI ARABIA SURGICAL SUTURE MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 337. SAUDI ARABIA SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2018-2024 (USD MILLION)
  • TABLE 338. SAUDI ARABIA SURGICAL SUTURE MARKET SIZE, BY BIODEGRADABILITY, 2025-2030 (USD MILLION)
  • TABLE 339. SAUDI ARABIA SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2018-2024 (USD MILLION)
  • TABLE 340. SAUDI ARABIA SURGICAL SUTURE MARKET SIZE, BY FILAMENT, 2025-2030 (USD MILLION)
  • TABLE 341. SAUDI ARABIA SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 342. SAUDI ARABIA SURGICAL SUTURE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 343. SAUDI ARABIA SURGICAL SUTURE MARKET SIZE, BY CARDIAC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 344. SAUDI ARABIA SURGICAL SUTURE MARKET SIZE, BY CARDIAC S